本頁面由Tiger Trade Technology Pte. Ltd.提供服務

enVVeno Medical Corp.

9.05
-0.2700-2.90%
盤後8.88-0.1700-1.88%19:30 EDT
成交量:3.93萬
成交額:34.15萬
市值:628.79萬
市盈率:-0.36
高:9.44
開:9.42
低:7.01
收:9.32
52周最高:35.70
52周最低:7.01
股本:69.48萬
流通股本:56.94萬
量比:0.59
換手率:6.90%
股息:- -
股息率:- -
每股收益(TTM):-24.8994
每股收益(LYR):-33.0600
淨資產收益率:-58.53%
總資產收益率:-36.67%
市淨率:0.30
市盈率(LYR):-0.27

資料載入中...

2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/02

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/12

重要事件披露

Form 8-K - Current report
2023/08/22

SEC問詢函

Form CORRESP - Correspondence
2023/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/26

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/04/28

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/02

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/10/27

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/11

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]